{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T03:51:23Z","timestamp":1792036283199,"version":"4.4.0"},"reference-count":130,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T00:00:00Z","timestamp":1791504000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Ageing Research Reviews"],"published-print":{"date-parts":[[2027,1]]},"DOI":"10.1016\/j.arr.2026.103399","type":"journal-article","created":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T15:26:12Z","timestamp":1791645972000},"page":"103399","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["The aging purinome: A purinergic framework linking the hallmarks of aging to inflammaging"],"prefix":"10.1016","volume":"123","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-9197-4777","authenticated-orcid":false,"given":"Bruna Cristina","family":"Ozelame","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e9ia Machado","family":"Cardoso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aline","family":"Manica","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.arr.2026.103399_bib1","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1038\/ncb2784","article-title":"A complex secretory program orchestrated by the inflammasome controls paracrine senescence","volume":"15","author":"Acosta","year":"2013","journal-title":"Nat. Cell. Biol."},{"key":"10.1016\/j.arr.2026.103399_bib2","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/S0736-5748(00)00023-X","article-title":"Age-related changes in the localization of P2X (nucleotide) receptors in the rat adrenal gland","volume":"18","author":"Afework","year":"2000","journal-title":"Int. J. Dev. Neurosci."},{"key":"10.1016\/j.arr.2026.103399_bib3","doi-asserted-by":"crossref","DOI":"10.1002\/mco2.359","article-title":"Purine and purinergic receptors in health and disease","volume":"4","author":"Ai","year":"2023","journal-title":"MedComm"},{"key":"10.1016\/j.arr.2026.103399_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2024.102540","article-title":"Immunosenescence and inflammaging: mechanisms and role in diseases","volume":"101","author":"Ajoolabady","year":"2024","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.arr.2026.103399_bib5","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1111\/imr.12528","article-title":"The ectonucleotidases CD 39 and CD 73: novel checkpoint inhibitor targets","volume":"276","author":"Allard","year":"2017","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.arr.2026.103399_bib6","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.molmed.2013.03.005","article-title":"CD39 and CD73 in immunity and inflammation","volume":"19","author":"Antonioli","year":"2013","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.arr.2026.103399_bib7","doi-asserted-by":"crossref","first-page":"2443","DOI":"10.1007\/s00262-023-03430-6","article-title":"First-in-human study of oleclumab, a potent, selective anti-CD73 monoclonal antibody, alone or in combination with durvalumab in patients with advanced solid tumors","volume":"72","author":"Bendell","year":"2023","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.arr.2026.103399_bib8","doi-asserted-by":"crossref","first-page":"2443","DOI":"10.1007\/s00262-023-03430-6","article-title":"First-in-human study of oleclumab, a potent, selective anti-CD73 monoclonal antibody, alone or in combination with durvalumab in patients with advanced solid tumors","volume":"72","author":"Bendell","year":"2023","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.arr.2026.103399_bib9","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/s00436-022-07698-y","article-title":"Curcumin modulates neurogliogenesis and purinergic receptor expression in neural precursor cells infected with Toxoplasma gondii","volume":"122","author":"Bissacotti","year":"2023","journal-title":"Parasitol. Res."},{"key":"10.1016\/j.arr.2026.103399_bib10","doi-asserted-by":"crossref","first-page":"950","DOI":"10.3390\/ph18070950","article-title":"Resveratrol alleviates inflammatory response through P2X7\/NLRP3 signaling pathway: in silico and in vitro evidence from activated microglia","volume":"18","author":"Bissacotti","year":"2025","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.arr.2026.103399_bib11","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1016\/j.bbadis.2019.01.004","article-title":"Adenosine receptors as a new target for resveratrol-mediated glioprotection","volume":"1865","author":"Bobermin","year":"2019","journal-title":"Biochim. Et. Biophys. Acta (BBA) - Mol. Basis Dis."},{"key":"10.1016\/j.arr.2026.103399_bib12","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1038\/s43587-025-00966-3","article-title":"A distinct population of CD8+ T cells expressing CD39 and CD73 accumulates with age and supports cancer progression","volume":"5","author":"Bodogai","year":"2025","journal-title":"Nat. Aging"},{"key":"10.1016\/j.arr.2026.103399_bib13","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/s11302-018-9634-3","article-title":"Resveratrol-mediated reversal of changes in purinergic signaling and immune response induced by Toxoplasma gondii infection of neural progenitor cells","volume":"15","author":"Bottari","year":"2019","journal-title":"Purinergic Signal."},{"key":"10.1016\/j.arr.2026.103399_bib14","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.tice.2017.07.001","article-title":"Ecto-5\u2032-nucleotidase (CD73) regulates bone formation and remodeling during intramembranous bone repair in aging mice","volume":"49","author":"Bradaschia-Correa","year":"2017","journal-title":"Tissue Cell."},{"key":"10.1016\/j.arr.2026.103399_bib15","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1161\/CIRCRESAHA.116.309726","article-title":"Purinergic signaling in the cardiovascular system","volume":"120","author":"Burnstock","year":"2017","journal-title":"Circ. Res."},{"key":"10.1016\/j.arr.2026.103399_bib16","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/s11302-015-9452-9","article-title":"Purinergic signalling during development and ageing","volume":"11","author":"Burnstock","year":"2015","journal-title":"Purinergic Signal."},{"key":"10.1016\/j.arr.2026.103399_bib17","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1007\/s11302-013-9359-2","article-title":"Purinergic signalling and diabetes","volume":"9","author":"Burnstock","year":"2013","journal-title":"Purinergic Signal."},{"key":"10.1016\/j.arr.2026.103399_bib18","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1124\/pr.113.008029","article-title":"Purinergic signaling and blood vessels in health and disease","volume":"66","author":"Burnstock","year":"2014","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.arr.2026.103399_bib19","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1016\/j.cmet.2016.05.006","article-title":"CD38 dictates age-related NAD decline and mitochondrial dysfunction through an SIRT3-dependent mechanism","volume":"23","author":"Camacho-Pereira","year":"2016","journal-title":"Cell. Metab."},{"key":"10.1016\/j.arr.2026.103399_bib20","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.3390\/cells9071612","article-title":"Purinergic signaling in the hallmarks of cancer","volume":"9","author":"Campos-Contreras","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.arr.2026.103399_bib21","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1097\/HJH.0000000000003529","article-title":"Resistance training reduces platelet activation in hypertensive women: the role of purinergic signaling","volume":"41","author":"Cardoso","year":"2023","journal-title":"J. Hypertens."},{"key":"10.1016\/j.arr.2026.103399_bib22","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1007\/s11302-025-10087-6","article-title":"The anti-inflammatory effect of physical exercise on type 2 diabetes: the role of purinergic signaling","volume":"21","author":"Cardoso","year":"2025","journal-title":"Purinergic Signal."},{"key":"10.1016\/j.arr.2026.103399_bib23","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1007\/s11302-021-09816-4","article-title":"Purinergic signaling as a new mechanism underlying physical exercise benefits: a narrative review","volume":"17","author":"Cardoso","year":"2021","journal-title":"Purinergic Signal."},{"key":"10.1016\/j.arr.2026.103399_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2022.115192","article-title":"Interplay between purinergic signalling and extracellular vesicles in health and disease","volume":"203","author":"Carotti","year":"2022","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.arr.2026.103399_bib25","doi-asserted-by":"crossref","first-page":"2593","DOI":"10.1158\/1078-0432.CCR-25-3727","article-title":"The randomized phase II ARC-9 study of etrumadenant-based therapy versus regorafenib in patients with previously treated metastatic colorectal cancer","volume":"32","author":"Cecchini","year":"2026","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.arr.2026.103399_bib26","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1007\/s11302-026-10136-8","article-title":"Mixed circuit training as a non-pharmacological strategy to improve platelet function and oxidative balance in type 2 diabetes: role of purinergic signaling","volume":"22","author":"Chaves","year":"2026","journal-title":"Purinergic Signal."},{"key":"10.1016\/j.arr.2026.103399_bib27","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/nrd3955","article-title":"Adenosine receptors as drug targets\u2014what are the challenges?","volume":"12","author":"Chen","year":"2013","journal-title":"Nat. Rev. Drug. Discov."},{"key":"10.1016\/j.arr.2026.103399_bib28","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1186\/s12885-018-4073-7","article-title":"Comprehensive evaluation of NT5E\/CD73 expression and its prognostic significance in distinct types of cancers","volume":"18","author":"Chen","year":"2018","journal-title":"BMC Cancer"},{"key":"10.1016\/j.arr.2026.103399_bib29","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.1158\/1078-0432.CCR-21-2742","article-title":"Phase I study of taminadenant (PBF509\/NIR178), an adenosine 2A receptor antagonist, with or without spartalizumab (PDR001), in patients with advanced non-small cell lung cancer","volume":"28","author":"Chiappori","year":"2022","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.arr.2026.103399_bib30","doi-asserted-by":"crossref","first-page":"3159","DOI":"10.1172\/JCI61636","article-title":"Purinergic P2Y14 receptor modulates stress-induced hematopoietic stem\/progenitor cell senescence","volume":"124","author":"Cho","year":"2014","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.arr.2026.103399_bib31","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1007\/s11302-018-9629-0","article-title":"Role of purinergic receptors in the Alzheimer\u2019s disease","volume":"14","author":"Cie\u015blak","year":"2018","journal-title":"Purinergic Signal."},{"key":"10.1016\/j.arr.2026.103399_bib32","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1146\/annurev-pathol-121808-102144","article-title":"The senescence-associated secretory phenotype: the dark side of tumor suppression","volume":"5","author":"Copp\u00e9","year":"2010","journal-title":"Annu. Rev. Pathol. Mech. Dis."},{"key":"10.1016\/j.arr.2026.103399_bib33","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.0060301","article-title":"Senescence-associated secretory phenotypes reveal cell-nonautonomous functions of oncogenic RAS and the p53 tumor suppressor","volume":"6","author":"Copp\u00e9","year":"2008","journal-title":"PLOS Biol."},{"key":"10.1016\/j.arr.2026.103399_bib34","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1007\/s004410100458","article-title":"Changes in expression of P2 receptors in rat and mouse pancreas during development and ageing","volume":"306","author":"Coutinho-Silva","year":"2001","journal-title":"Cell. Tissue Res."},{"key":"10.1016\/j.arr.2026.103399_bib35","doi-asserted-by":"crossref","first-page":"4609","DOI":"10.1158\/1078-0432.CCR-24-0499","article-title":"A phase Ib\/II randomized clinical trial of oleclumab with or without durvalumab plus chemotherapy in patients with metastatic pancreatic ductal adenocarcinoma","volume":"30","author":"Coveler","year":"2024","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.arr.2026.103399_bib36","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/1742-2094-6-24","article-title":"Expression of P2 nucleotide receptors varies with age and sex in murine brain microglia","volume":"6","author":"Crain","year":"2009","journal-title":"J. Neuroinflamm."},{"issue":"2","key":"10.1016\/j.arr.2026.103399_bib37","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1046\/j.1471-4159.2001.00095.x","article-title":"Parallel modification of adenosine extracellular metabolism and modulatory action in the hippocampus of aged rats","volume":"76","author":"Cunha","year":"2001","journal-title":"J. Neurochem."},{"key":"10.1016\/j.arr.2026.103399_bib38","doi-asserted-by":"crossref","DOI":"10.1098\/rstb.2014.0191","article-title":"ATP release through pannexon channels","volume":"370","author":"Dahl","year":"2015","journal-title":"Philos. Trans. R. Soc. B"},{"key":"10.1016\/j.arr.2026.103399_bib39","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1007\/s00394-016-1373-z","article-title":"Fish oil supplementation attenuates neuroinflammation and alleviates depressive-like behavior in rats submitted to repeated lipopolysaccharide","volume":"57","author":"Dang","year":"2018","journal-title":"Eur. J. Nutr."},{"key":"10.1016\/j.arr.2026.103399_bib40","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1038\/s41580-020-00314-w","article-title":"Cellular senescence in ageing: from mechanisms to therapeutic opportunities","volume":"22","author":"Di Micco","year":"2021","journal-title":"Nat. Rev. Mol. Cell. Biol."},{"key":"10.1016\/j.arr.2026.103399_bib41","doi-asserted-by":"crossref","first-page":"C832","DOI":"10.1152\/ajpcell.00053.2020","article-title":"Purinergic signaling, DAMPs, and inflammation","volume":"318","author":"Di Virgilio","year":"2020","journal-title":"Am. J. Physiol. -Cell. Physiol."},{"key":"10.1016\/j.arr.2026.103399_bib42","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1038\/s41577-019-0240-6","article-title":"Efferocytosis in health and disease","volume":"20","author":"Doran","year":"2020","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.arr.2026.103399_bib43","doi-asserted-by":"crossref","DOI":"10.1111\/acel.13761","article-title":"P2Y6 receptor-dependent microglial phagocytosis of synapses mediates synaptic and memory loss in aging","volume":"22","author":"Dundee","year":"2023","journal-title":"Aging Cell."},{"key":"10.1016\/j.arr.2026.103399_bib44","doi-asserted-by":"crossref","first-page":"2322","DOI":"10.1056\/NEJMra1205750","article-title":"Purinergic signaling during inflammation","volume":"367","author":"Eltzschig","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.arr.2026.103399_bib45","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1111\/febs.16585","article-title":"The role of extracellular vesicles in cellular senescence","volume":"290","author":"Est\u00e9vez-Souto","year":"2023","journal-title":"FEBS J."},{"issue":"6","key":"10.1016\/j.arr.2026.103399_bib46","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.109981","article-title":"The cell-surface 5\u2032-nucleotidase CD73 defines a functional T memory cell subset that declines with age","volume":"37","author":"Fang","year":"2021","journal-title":"Cell Rep."},{"issue":"5","key":"10.1016\/j.arr.2026.103399_bib47","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1016\/j.celrep.2016.01.002","article-title":"Expression of CD39 on Activated T Cells Impairs their Survival in Older Individuals","volume":"14","author":"Fang","year":"2016","journal-title":"Cell Rep."},{"key":"10.1016\/j.arr.2026.103399_bib48","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1158\/2159-8290.CD-19-0980","article-title":"Adenosine 2A receptor blockade as an immunotherapy for treatment-refractory renal cell cancer","volume":"10","author":"Fong","year":"2020","journal-title":"Cancer Discov."},{"key":"10.1016\/j.arr.2026.103399_bib49","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1111\/j.1749-6632.2000.tb06651.x","article-title":"Inflamm-aging: an evolutionary perspective on immunosenescence","volume":"908","author":"Franceschi","year":"2000","journal-title":"Ann. New. Y. Acad. Sci."},{"key":"10.1016\/j.arr.2026.103399_bib50","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1093\/gerona\/glu057","article-title":"Chronic inflammation (Inflammaging) and its potential contribution to age-associated diseases","volume":"69","author":"Franceschi","year":"2014","journal-title":"J. Gerontol. Ser. A Biol. Sci. Med. Sci."},{"key":"10.1016\/j.arr.2026.103399_bib51","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.mad.2006.11.016","article-title":"Inflammaging and anti-inflammaging: a systemic perspective on aging and longevity emerged from studies in humans","volume":"128","author":"Franceschi","year":"2007","journal-title":"Mech. Ageing Dev."},{"key":"10.1016\/j.arr.2026.103399_bib52","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1038\/s41574-018-0059-4","article-title":"Inflammaging: a new immune\u2013metabolic viewpoint for age-related diseases","volume":"14","author":"Franceschi","year":"2018","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/j.arr.2026.103399_bib53","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.tem.2016.09.005","article-title":"Inflammaging and \u2018Garb-aging","volume":"28","author":"Franceschi","year":"2017","journal-title":"Trends Endocrinol. & Metab."},{"key":"10.1016\/j.arr.2026.103399_bib54","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1038\/s43587-025-00938-7","article-title":"Toward precision interventions and metrics of inflammaging","volume":"5","author":"Franceschi","year":"2025","journal-title":"Nat. Aging"},{"key":"10.1016\/j.arr.2026.103399_bib55","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.smim.2018.10.008","article-title":"Inflammaging 2018: an update and a model","volume":"40","author":"Franceschi","year":"2018","journal-title":"Semin. Immunol."},{"key":"10.1016\/j.arr.2026.103399_bib56","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1007\/s00011-022-01560-8","article-title":"Inflammatory profile in cervical cancer: influence of purinergic signaling and possible therapeutic targets","volume":"71","author":"Franciosi","year":"2022","journal-title":"Inflamm. Res."},{"key":"10.1016\/j.arr.2026.103399_bib57","doi-asserted-by":"crossref","first-page":"94","DOI":"10.3389\/fnmol.2020.00094","article-title":"The role of P2X7 receptor in alzheimer\u2019s disease","volume":"13","author":"Francistiov\u00e1","year":"2020","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.arr.2026.103399_bib58","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1038\/nrd.2016.39","article-title":"Resolution of inflammation: a new therapeutic frontier","volume":"15","author":"Fullerton","year":"2016","journal-title":"Nat. Rev. Drug. Discov."},{"key":"10.1016\/j.arr.2026.103399_bib59","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1455469","article-title":"The potential role of purinergic signaling in cancer therapy: perspectives on anti-CD73 strategies for prostate cancer","volume":"15","author":"Gardani","year":"2024","journal-title":"Front. Immunol."},{"key":"10.1016\/j.arr.2026.103399_bib60","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbcan.2023.189024","article-title":"Apoptosis, necroptosis, and pyroptosis as alternative cell death pathways induced by chemotherapeutic agents?","volume":"1878","author":"Gieleci\u0144ska","year":"2023","journal-title":"Biochimica et Biophysica Acta (BBA) - Reviews Cancer"},{"key":"10.1016\/j.arr.2026.103399_bib61","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.cmet.2020.06.006","article-title":"Adenosine\/A2B receptor signaling ameliorates the effects of aging and counteracts obesity","volume":"32","author":"Gnad","year":"2020","journal-title":"Cell. Metab."},{"key":"10.1016\/j.arr.2026.103399_bib62","doi-asserted-by":"crossref","first-page":"832","DOI":"10.3389\/fimmu.2018.00832","article-title":"Mitochondrial damage-associated molecular patterns: from inflammatory signaling to human diseases","volume":"9","author":"Grazioli","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.arr.2026.103399_bib63","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1124\/jpet.113.210849","article-title":"BAY60-6583 acts as a partial agonist at adenosine A2B receptors","volume":"349","author":"Hinz","year":"2014","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.arr.2026.103399_bib64","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.3389\/fimmu.2019.01187","article-title":"The multi-faceted ecto-enzyme CD38: roles in immunomodulation, cancer, aging, and metabolic diseases","volume":"10","author":"Hogan","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.arr.2026.103399_bib65","doi-asserted-by":"crossref","first-page":"4375","DOI":"10.1113\/JP284980","article-title":"Age-related changes in P2Y receptor signalling in mouse cochlear supporting cells","volume":"601","author":"Hool","year":"2023","journal-title":"J. Physiol."},{"key":"10.1016\/j.arr.2026.103399_bib66","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1038\/s41392-021-00553-z","article-title":"From purines to purinergic signalling: molecular functions and human diseases","volume":"6","author":"Huang","year":"2021","journal-title":"Signal. Transduct. Target. Ther."},{"key":"10.1016\/j.arr.2026.103399_bib67","doi-asserted-by":"crossref","first-page":"2866","DOI":"10.1007\/s12035-023-03699-9","article-title":"P2X7 Receptor: an emerging target in alzheimer\u2019s disease","volume":"61","author":"Huang","year":"2024","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.arr.2026.103399_bib68","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1111\/bph.15299","article-title":"Update of P2X receptor properties and their pharmacology: IUPHAR Review 30","volume":"178","author":"Illes","year":"2021","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.arr.2026.103399_bib69","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2020.114393","article-title":"Purinergic signaling in diabetes and metabolism","volume":"187","author":"Jain","year":"2021","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.arr.2026.103399_bib70","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/s41392-023-01502-8","article-title":"Inflammation and aging: signaling pathways and intervention therapies","volume":"8","author":"Li","year":"2023","journal-title":"Signal. Transduct. Target. Ther."},{"key":"10.1016\/j.arr.2026.103399_bib71","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1146\/annurev-immunol-051116-052406","article-title":"Purine release, metabolism, and signaling in the inflammatory response","volume":"37","author":"Linden","year":"2019","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.arr.2026.103399_bib72","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1016\/j.febslet.2014.02.004","article-title":"Differentiating connexin hemichannels and pannexin channels in cellular ATP release","volume":"588","author":"Lohman","year":"2014","journal-title":"FEBS Lett."},{"key":"10.1016\/j.arr.2026.103399_bib73","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.654023","article-title":"Role of ATP in EXtracellular Vesicle Biogenesis and Dynamics","volume":"12","author":"Lombardi","year":"2021","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.arr.2026.103399_bib74","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.cyto.2019.01.013","article-title":"The senescence-associated secretory phenotype and its regulation","volume":"117","author":"Lopes-Paciencia","year":"2019","journal-title":"Cytokine"},{"key":"10.1016\/j.arr.2026.103399_bib75","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1016\/j.cell.2013.05.039","article-title":"The hallmarks of aging","volume":"153","author":"L\u00f3pez-Ot\u00edn","year":"2013","journal-title":"Cell"},{"key":"10.1016\/j.arr.2026.103399_bib76","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.cell.2022.11.001","article-title":"Hallmarks of aging: an expanding universe","volume":"186","author":"L\u00f3pez-Ot\u00edn","year":"2023","journal-title":"Cell"},{"key":"10.1016\/j.arr.2026.103399_bib77","doi-asserted-by":"crossref","first-page":"3980","DOI":"10.1002\/jcb.26551","article-title":"High levels of extracellular ATP lead to chronic inflammatory response in melanoma patients","volume":"119","author":"Manica","year":"2018","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.arr.2026.103399_bib78","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1007\/s11302-024-10054-7","article-title":"P2 purinergic receptor expression and function in tumor-related immune cells","volume":"21","author":"Manoharan","year":"2025","journal-title":"Purinergic Signal."},{"key":"10.1016\/j.arr.2026.103399_bib79","doi-asserted-by":"crossref","first-page":"16904","DOI":"10.3390\/ijms242316904","article-title":"Energy regulation in inflammatory sarcopenia by the purinergic system","volume":"24","author":"Marco-Bonilla","year":"2023","journal-title":"IJMS"},{"key":"10.1016\/j.arr.2026.103399_bib80","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1038\/s41467-018-03421-7","article-title":"Chronic nicotinamide riboside supplementation is well-tolerated and elevates NAD+ in healthy middle-aged and older adults","volume":"9","author":"Martens","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.arr.2026.103399_bib81","doi-asserted-by":"crossref","first-page":"329","DOI":"10.3389\/fendo.2020.00329","article-title":"Purinergic signaling during hyperglycemia in vascular smooth muscle cells","volume":"11","author":"Martin-Aragon Baudel","year":"2020","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.arr.2026.103399_bib82","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1055\/s-0042-114218","article-title":"Exercise training positively modulates the ectonucleotidase enzymes in lymphocytes of metabolic syndrome patients","volume":"37","author":"Martins","year":"2016","journal-title":"Int. J. Sports Med."},{"issue":"5","key":"10.1016\/j.arr.2026.103399_bib83","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1002\/jnr.20314","article-title":"Ageing\u2010related decline in adenosine A1 receptor binding in the rat brain: An autoradiographic study","volume":"78","author":"Meerlo","year":"2004","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.arr.2026.103399_bib84","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1007\/s11302-024-10029-8","article-title":"Microglial purinergic signaling in Alzheimer\u2019s disease","volume":"21","author":"Mei","year":"2025","journal-title":"Purinergic Signal."},{"key":"10.1016\/j.arr.2026.103399_bib85","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.3390\/cells10051267","article-title":"Alzheimer and purinergic signaling: just a matter of inflammation?","volume":"10","author":"Merighi","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.arr.2026.103399_bib86","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s10522-022-10000-3","article-title":"Age-dependent and modality-specific changes in the phenotypic markers Nav1.8, ASIC3, P2X3 and TRPM8 in male rat primary sensory neurons during healthy aging","volume":"24","author":"Messina","year":"2023","journal-title":"Biogerontology"},{"key":"10.1016\/j.arr.2026.103399_bib87","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.neuro.2023.10.011","article-title":"Resistance physical exercise alleviates lipopolysaccharide-triggered neuroinflammation in cortex and hippocampus of rats via purinergic signaling","volume":"99","author":"Miron","year":"2023","journal-title":"NeuroToxicology"},{"key":"10.1016\/j.arr.2026.103399_bib88","doi-asserted-by":"crossref","first-page":"3232","DOI":"10.1002\/jcb.27590","article-title":"Physical exercise prevents alterations in purinergic system and oxidative status in lipopolysaccharide-induced sepsis in rats","volume":"120","author":"Miron","year":"2019","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.arr.2026.103399_bib89","doi-asserted-by":"crossref","DOI":"10.1172\/JCI158447","article-title":"Mitochondrial dysfunction in cell senescence and aging","volume":"132","author":"Miwa","year":"2022","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.arr.2026.103399_bib90","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1007\/s10495-021-01663-3","article-title":"Release mechanisms of major DAMPs","volume":"26","author":"Murao","year":"2021","journal-title":"Apoptosis"},{"key":"10.1016\/j.arr.2026.103399_bib91","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2023.109541","article-title":"P2 receptor-mediated signaling in the physiological and pathological brain: from development to aging and disease","volume":"233","author":"Mut-Arbona","year":"2023","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.arr.2026.103399_bib92","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1038\/s12276-025-01527-9","article-title":"Targeting immunosenescence and inflammaging: advancing longevity research","volume":"57","author":"Nguyen","year":"2025","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.arr.2026.103399_bib93","doi-asserted-by":"crossref","first-page":"8517","DOI":"10.1073\/pnas.1200189109","article-title":"Omega-3 fatty acids cause dramatic changes in TLR4 and purinergic eicosanoid signaling","volume":"109","author":"Norris","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.arr.2026.103399_bib94","doi-asserted-by":"crossref","first-page":"17","DOI":"10.3390\/biology14010017","article-title":"Molecular and cellular mechanisms of immunosenescence: modulation through interventions and lifestyle changes","volume":"14","author":"Pangrazzi","year":"2024","journal-title":"Biology"},{"key":"10.1016\/j.arr.2026.103399_bib95","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.biopha.2018.02.029","article-title":"Effect of gallic acid on purinergic signaling in lymphocytes, platelets, and serum of diabetic rats","volume":"101","author":"Pereira","year":"2018","journal-title":"Biomed. & Pharmacother."},{"issue":"n. 3","key":"10.1016\/j.arr.2026.103399_bib96","first-page":"62","article-title":"Purinergic system and cervical cancer: perspectives 2","volume":"v. 2","author":"Pfaffenzeller","year":"2020","journal-title":"J. Cancer Immunol."},{"key":"10.1016\/j.arr.2026.103399_bib97","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/s11302-020-09693-3","article-title":"Purinergic signaling and tumor microenvironment in cervical Cancer","volume":"16","author":"Pfaffenzeller","year":"2020","journal-title":"Purinergic Signal."},{"key":"10.1016\/j.arr.2026.103399_bib98","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.mito.2016.07.003","article-title":"The rise of mitochondria in medicine","volume":"30","author":"Picard","year":"2016","journal-title":"Mitochondrion"},{"key":"10.1016\/j.arr.2026.103399_bib99","doi-asserted-by":"crossref","first-page":"933","DOI":"10.3390\/ijms18050933","article-title":"Fueling inflamm-aging through mitochondrial dysfunction: mechanisms and molecular targets","volume":"18","author":"Picca","year":"2017","journal-title":"IJMS"},{"key":"10.1016\/j.arr.2026.103399_bib100","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2021.654850","article-title":"Glial purinergic signaling in neurodegeneration","volume":"12","author":"Pietrowski","year":"2021","journal-title":"Front. Neurol."},{"key":"10.1016\/j.arr.2026.103399_bib101","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2025.102695","article-title":"Adenosine metabolism and receptors in aging of the skin, musculoskeletal, immune and cardiovascular systems","volume":"106","author":"Rabbani","year":"2025","journal-title":"Ageing Res. Rev."},{"issue":"2","key":"10.1016\/j.arr.2026.103399_bib102","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1152\/jn.00896.2002","article-title":"Enhanced adenosine A2A receptor facilitation of synaptic transmission in the hippocampus of aged rats","volume":"90","author":"Rebola","year":"2003","journal-title":"J. Neurophysiol."},{"key":"10.1016\/j.arr.2026.103399_bib103","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1038\/s41398-023-02557-5","article-title":"Characterization of the central nervous system penetrant and selective purine P2X7 receptor antagonist JNJ-54175446 in patients with major depressive disorder","volume":"13","author":"Recourt","year":"2023","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.arr.2026.103399_bib104","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.111273","article-title":"Diabetes and hypertension: pivotal involvement of purinergic signaling","volume":"137","author":"Reichert","year":"2021","journal-title":"Biomed. & Pharmacother."},{"key":"10.1016\/j.arr.2026.103399_bib105","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2021.101422","article-title":"Immunosenescence and inflammaging in the aging process: age-related diseases or longevity?","volume":"71","author":"Santoro","year":"2021","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.arr.2026.103399_bib106","doi-asserted-by":"crossref","first-page":"6829","DOI":"10.18632\/aging.204248","article-title":"New hallmarks of ageing: a 2022 Copenhagen ageing meeting summary","volume":"14","author":"Schmauck-Medina","year":"2022","journal-title":"Aging"},{"key":"10.1016\/j.arr.2026.103399_bib107","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2019.101000","article-title":"The effect of ageing on the resolution of inflammation","volume":"57","author":"Sendama","year":"2020","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.arr.2026.103399_bib108","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/s11302-024-10036-9","article-title":"P2Y11 receptor is a critical regulator of extracellular ATP-mediated premature senescence in lung fibroblasts: implications of ER-Ca+2 release\/mitochondrial ROS production signaling pathway","volume":"21","author":"Shatat","year":"2025","journal-title":"Purinergic Signal."},{"key":"10.1016\/j.arr.2026.103399_bib109","doi-asserted-by":"crossref","first-page":"8474","DOI":"10.3390\/ijms26178474","article-title":"Targeting the purinergic axis with phenolic compounds to disrupt the oxidative-inflammatory cycle in thyroid cancer","volume":"26","author":"Sim\u00f5es","year":"2025","journal-title":"IJMS"},{"key":"10.1016\/j.arr.2026.103399_bib110","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1038\/s41420-025-02295-1","article-title":"Age-associated microglial transcriptome leads to diminished immunogenicity and dysregulation of MCT4 and P2RY12\/P2RY13 related functions","volume":"11","author":"\u0160kand\u00edk","year":"2025","journal-title":"Cell. Death Discov."},{"key":"10.1016\/j.arr.2026.103399_bib111","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1023\/A:1004110529753","article-title":"The purinergic calcium channels P2X1,2,5,7 are down-regulated while P2X3,4,6 are up-regulated during apoptosis in the ageing rat prostate","volume":"32","author":"Slater","year":"2000","journal-title":"Histochem. J."},{"key":"10.1016\/j.arr.2026.103399_bib112","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2025.117050","article-title":"NAD+ glycohydrolases-CD38 as a therapeutic target in aging: physiological roles, molecular mechanisms, and future opportunities in anti-aging research","volume":"239","author":"Sun","year":"2025","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.arr.2026.103399_bib113","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.phrs.2017.03.013","article-title":"Purinergic P2Y6 receptors: a new therapeutic target of age-dependent hypertension","volume":"120","author":"Sunggip","year":"2017","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.arr.2026.103399_bib114","doi-asserted-by":"crossref","DOI":"10.1111\/acel.12734","article-title":"Emerging roles of extracellular vesicles in cellular senescence and aging","volume":"17","author":"Takasugi","year":"2018","journal-title":"Aging Cell."},{"key":"10.1016\/j.arr.2026.103399_bib115","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1186\/s13045-020-00946-7","article-title":"Ferroptosis, necroptosis, and pyroptosis in anticancer immunity","volume":"13","author":"Tang","year":"2020","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.arr.2026.103399_bib116","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1038\/s41380-018-0110-9","article-title":"Age-related shift in LTD is dependent on neuronal adenosine A2A receptors interplay with mGluR5 and NMDA receptors","volume":"25","author":"Temido-Ferreira","year":"2020","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.arr.2026.103399_bib117","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1177\/0269881118800067","article-title":"Clinical pharmacokinetics, pharmacodynamics, safety, and tolerability of JNJ-54175446, a brain permeable P2X7 antagonist, in a randomised single-ascending dose study in healthy participants","volume":"32","author":"Timmers","year":"2018","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.arr.2026.103399_bib118","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2024.107145","article-title":"Purinergic signaling promotes premature senescence","volume":"300","author":"Volonte","year":"2024","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.arr.2026.103399_bib119","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2024.107145","article-title":"Purinergic signaling promotes premature senescence","volume":"300","author":"Volont\u00e9","year":"2024","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.arr.2026.103399_bib120","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.neuropharm.2005.08.019","article-title":"Changes in purinergic signalling in developing and ageing rat tail artery: Importance for temperature control","volume":"50","author":"Wallace","year":"2006","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.arr.2026.103399_bib121","doi-asserted-by":"crossref","DOI":"10.1016\/j.mad.2020.111263","article-title":"The bright and dark side of extracellular vesicles in the senescence-associated secretory phenotype","volume":"189","author":"Wallis","year":"2020","journal-title":"Mech. Ageing Dev."},{"key":"10.1016\/j.arr.2026.103399_bib122","doi-asserted-by":"crossref","first-page":"57327","DOI":"10.18632\/oncotarget.16905","article-title":"Prognostic value of CD73-adenosinergic pathway in solid tumor: a meta-analysis and systematic review","volume":"8","author":"Wang","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.arr.2026.103399_bib123","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1038\/nri2975","article-title":"Mitochondria in innate immune responses","volume":"11","author":"West","year":"2011","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.arr.2026.103399_bib124","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1007\/s10753-014-0036-6","article-title":"Trans-resveratrol attenuates high fatty acid-induced P2X7 REceptor Expression and IL-6 release in PC12 cells: possible role of P38 MAPK pathway","volume":"38","author":"Xu","year":"2015","journal-title":"Inflammation"},{"key":"10.1016\/j.arr.2026.103399_bib125","doi-asserted-by":"crossref","DOI":"10.1002\/jev2.12154","article-title":"Roles of extracellular vesicles in the aging microenvironment and age-related diseases","volume":"10","author":"Yin","year":"2021","journal-title":"J. Extracell. Vesicle"},{"key":"10.1016\/j.arr.2026.103399_bib126","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1126\/science.abe9985","article-title":"Nicotinamide mononucleotide increases muscle insulin sensitivity in prediabetic women","volume":"372","author":"Yoshino","year":"2021","journal-title":"Science"},{"key":"10.1016\/j.arr.2026.103399_bib127","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.intimp.2018.12.012","article-title":"Curcumin relieves depressive-like behaviors via inhibition of the NLRP3 inflammasome and kynurenine pathway in rats suffering from chronic unpredictable mild stress","volume":"67","author":"Zhang","year":"2019","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.arr.2026.103399_bib128","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.82206","article-title":"Connexin 43 hemichannels regulate mitochondrial ATP generation, mobilization, and mitochondrial homeostasis against oxidative stress","volume":"11","author":"Zhang","year":"2022","journal-title":"eLife"},{"key":"10.1016\/j.arr.2026.103399_bib129","article-title":"Unveiling the role of NAD glycohydrolase CD38 in aging and age-related diseases: insights from bibliometric analysis and comprehensive review","volume":"16","author":"Zhao","year":"2025","journal-title":"Front. Immunol."},{"key":"10.1016\/j.arr.2026.103399_bib130","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.yjmcc.2020.02.004","article-title":"Alteration of purinergic signaling in diabetes: focus on vascular function","volume":"140","author":"Zhou","year":"2020","journal-title":"J. Mol. Cell. Cardiol."}],"container-title":["Ageing Research Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568163726003910?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568163726003910?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T03:35:32Z","timestamp":1792035332000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1568163726003910"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2027,1]]},"references-count":130,"alternative-id":["S1568163726003910"],"URL":"https:\/\/doi.org\/10.1016\/j.arr.2026.103399","relation":{},"ISSN":["1568-1637"],"issn-type":[{"value":"1568-1637","type":"print"}],"subject":[],"published":{"date-parts":[[2027,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The aging purinome: A purinergic framework linking the hallmarks of aging to inflammaging","name":"articletitle","label":"Article Title"},{"value":"Ageing Research Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.arr.2026.103399","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"103399"}}